Open Access
J Extra Corpor Technol
Volume 38, Number 1, March 2006
Page(s) 44 - 47
Published online 15 March 2006
  1. Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care. 2003;26:917–32. [CrossRef] [PubMed] [Google Scholar]
  2. Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care 1990;13:513–21. [Google Scholar]
  3. Singer AJ, Clark RAF. Cutaneous wound healing. N Engl J Med. 1999;341:738–46. [CrossRef] [PubMed] [Google Scholar]
  4. Argenta LC, Morykwas MJ. Vacuum-assisted closure: a new method for wound control and treatment: clinical experience. Ann Plast Surg. 1997;38:563–76. [CrossRef] [PubMed] [Google Scholar]
  5. Steed DL, Goslen JB, Holloway GA, Malone JM, Bunt TJ, Webster MW. Randomized prospective double-blind trial in healing chronic diabetic foot ulcers. CT-102 activated platelet supernatant, topical versus placebo. Diabetes Care. 1992;15:598–604. [Google Scholar]
  6. Robson MC. The role of growth factors in the healing of chronic wounds. Wound Repair Regen. 1997;5:12–7. [CrossRef] [PubMed] [Google Scholar]
  7. Man D, Plosker H, Winland-Brown JE. The use of autologous platelet-rich plasma (platelet gel) and autologous platelet-poor plasma (fibrin glue) in cosmetic surgery. Plast Reconstr Surg. 2001;107:229–39. [CrossRef] [PubMed] [Google Scholar]
  8. Cromack DT, Porras-Reyes B, Mustoe TA. Current concepts in wound healing: growth factor and macrophage interaction. J Trauma. 1990;30(12 suppl):S129–33. [Google Scholar]
  9. Yazbek N, Bapat A, Kleiman N. Platelet abnormalities in diabetes mellitus. Coron Artery Dis. 2003;14:365–71. [Google Scholar]
  10. Fateh-Moghadam S, Li Z, Ersel S, et al. Platelet degranulation is associated with progression of intima-media thickness of the common carotid artery in patients with diabetes mellitus type 2. Arterioscler Thromb Vasc Biol. 2005;25:1299–303. [CrossRef] [PubMed] [Google Scholar]
  11. Guillausseau PJ, Dupuy E, Bryckaert MC, et al. Platelet-derived growth factor (PDGF) in type 1 diabetes mellitus. Eur J Clin Invest. 1989;19:172–5. [CrossRef] [PubMed] [Google Scholar]
  12. Yager DR, Chen SM, Ward SI, Olutoye O, Diegelmann RF, Cohen K. Ability of chronic wound fluids to degrade peptide growth factors is associated with increased levels of elastase activity and diminished levels of proteinase inhibitors. Wound Repair Regen. 1997;5:23–32. [CrossRef] [PubMed] [Google Scholar]
  13. Nolan CM, Beaty HN, Bagdade JD. Further characterization of the impaired bactericidal function of granulocytes in patients with poorly controlled diabetes. Diabetes. 1978;27:889–94. [CrossRef] [PubMed] [Google Scholar]
  14. Hamet P, Sugimoto H, Umeda F, et al. Abnormalities of platelet-derived growth factors in insulin-dependent diabetes. Metabolism. 1985;34(12 suppl 1):25–31. [CrossRef] [PubMed] [Google Scholar]
  15. Moore K. Compromised wound healing: a scientific approach to treatment. Br J Community Nurs. 2003;8:274–8. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.